Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px
Document › Details

OBN (UK) Ltd.. (1/19/17). "Press Release: OBN Appoints Mark Hooper as Head of Business Development". Abingdon.

Region Region Oxford, Oxfordshire
  Country United Kingdom (GB)
Organisations Organisation OBN (UK) Ltd.
  Organisation 2 Pharmaterials Ltd.
  Group Quotient (Group)
Products Product business development (state/region)
  Product 2 LIFE SCIENCES
Persons Person Hooper, Mark (OBN 201701– Head Business Development before Conversis Medical + Pharmaterials + Johnson Matthey)
  Person 2 Harris, John G. (OBN 201604 CEO)
     


OBN, the Membership organisation supporting the UK’s innovative life sciences companies, announced today the appointment of Mark Hooper as the new Head of Business Development with immediate effect.

Mark has over 15 years’ experience in the life sciences industry, with a thorough knowledge of the pharmaceutical drug development process, from discovery to development as well as clinical trials and commercial sales. He started work as a research chemist and progressed to be Technical Sales Manager at Johnson Matthey following which he worked in various Director roles at Pharmaterials, a contract research organisation, including business development, project management and screening, running an analytical/QC group and supporting patent disputes in the high court. More recently, he was Director at Conversis Medical, a translation company, where his business development role covered clinical trials, patient engagement and commercial launch. Mark has an MBA from Warwick, a DPhil and BA (Chem) from Oxford and carried out PostDoc studies at Yale.

John Harris, CEO, OBN said: “We are delighted that Mark has joined us in this key role, his background perfectly complements the many facets of OBN and we are looking forward to reaping the rewards of his experience.”

Mark Hooper commented: “I am excited to be part of OBN as I passionately believe that great innovation coupled with solid investment and dynamic support makes for a thriving life sciences sector, of which the UK is a world leader.”

   
Record changed: 2019-07-18

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

More documents for OBN (UK) Ltd.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 650x80px




» top